Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Jacques Gonvers

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Digestion|February 2, 2008
Extraintestinal manifestations of Crohn's diseasePascal Juillerat, Christian Mottet, Valérie Pittet, et al.
Digestion|February 2, 2008
Pregnancy and breastfeeding in patients with Crohn's diseaseChristian Mottet, Pascal Juillerat, Valérie Pittet, et al.
Digestion|February 16, 2005
Drug safety in the treatment of Crohn's diseasePascal Juillerat, Christian Felley, Christian Mottet, et al.
Digestion|February 16, 2005
Severe and steroid-resistant Crohn's diseasePierre Michetti, Christian Mottet, Pascal Juillerat, et al.
Digestion|February 16, 2005
Obstructive fibrostenotic Crohn's diseaseFlorian Froehlich, Pascal Juillerat, Christian Mottet, et al.
Digestion|February 16, 2005
Treatment of gastroduodenal Crohn's diseaseChristian Mottet, Pascal Juillerat, Jean-Jacques Gonvers, et al.
Digestion|February 2, 2008
Drug safety in Crohn's disease therapyPascal Juillerat, Valérie Pittet, Christian Felley, et al.
Digestion|March 19, 2005
The EPAGE internet guideline as a decision support tool for determining the appropriateness of colonoscopyOlivier Terraz, Vincent Wietlisbach, Jean-Gabriel Jeannot, et al.
Journal of Crohn'S & Colitis|May 14, 2013
When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panelValerie Pittet, Florian Froehlich, Michel H Maillard, et al.
Journal of Crohn'S & Colitis|January 28, 2014
Appropriateness and long-term discontinuation rate of biological therapies in ulcerative colitisMichel H Maillard, Murielle Bortolotti, John-Paul Vader, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Digestion|February 2, 2008
Extraintestinal manifestations of Crohn's diseasePascal Juillerat, Christian Mottet, Valérie Pittet, et al.
Digestion|February 2, 2008
Pregnancy and breastfeeding in patients with Crohn's diseaseChristian Mottet, Pascal Juillerat, Valérie Pittet, et al.
Digestion|February 16, 2005
Drug safety in the treatment of Crohn's diseasePascal Juillerat, Christian Felley, Christian Mottet, et al.
Digestion|February 16, 2005
Severe and steroid-resistant Crohn's diseasePierre Michetti, Christian Mottet, Pascal Juillerat, et al.
Digestion|February 16, 2005
Obstructive fibrostenotic Crohn's diseaseFlorian Froehlich, Pascal Juillerat, Christian Mottet, et al.
Digestion|February 16, 2005
Treatment of gastroduodenal Crohn's diseaseChristian Mottet, Pascal Juillerat, Jean-Jacques Gonvers, et al.
Digestion|February 2, 2008
Drug safety in Crohn's disease therapyPascal Juillerat, Valérie Pittet, Christian Felley, et al.
Digestion|March 19, 2005
The EPAGE internet guideline as a decision support tool for determining the appropriateness of colonoscopyOlivier Terraz, Vincent Wietlisbach, Jean-Gabriel Jeannot, et al.
Journal of Crohn'S & Colitis|May 14, 2013
When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panelValerie Pittet, Florian Froehlich, Michel H Maillard, et al.
Journal of Crohn'S & Colitis|January 28, 2014
Appropriateness and long-term discontinuation rate of biological therapies in ulcerative colitisMichel H Maillard, Murielle Bortolotti, John-Paul Vader, et al.
Pageof 6